(Q37176655)

18 August 2017

1 reference

title

Effects of antiretroviral therapy on cognitive impairment (English)

1 reference

18 August 2017

main subject

anti-retroviral agent

0 references

cognitive dysfunction

1 reference

Kevin J Liner

1

1 reference

18 August 2017

Colin D Hall

series ordinal

2

1 reference

18 August 2017

Kevin R Robertson

series ordinal

3

1 reference

18 August 2017

publication date

1 May 2008

1 reference

18 August 2017

published in

Current HIV/AIDS reports

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

64-71

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-008-0011-7

18 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11904-008-0011-7

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-008-0011-7

Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-008-0011-7

Response to systemic HIV viral load suppression correlates with psychomotor speed performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-008-0011-7

Two phases of HIV RNA decay in CSF during initial days of multidrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-008-0011-7

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-008-0011-7

Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment

21 January 2018

1 reference

12 December 2020

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

1 reference

12 December 2020

Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

1 reference

12 December 2020

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

1 reference

12 December 2020

Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS.

1 reference

12 December 2020

Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations

1 reference

12 December 2020

HIV-associated cognitive impairment in sub-Saharan Africa--the potential effect of clade diversity

1 reference

12 December 2020

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

1 reference

12 December 2020

Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method

1 reference

12 December 2020

Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy.

1 reference

12 December 2020

Antiretroviral treatment of central nervous system HIV-1 infection: a review

1 reference

12 December 2020

Timed Gait test: normative data for the assessment of the AIDS dementia complex

1 reference

12 December 2020

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients

1 reference

12 December 2020

The prevalence and incidence of neurocognitive impairment in the HAART era.

1 reference

12 December 2020

Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo

1 reference

12 December 2020

HAART & the molecular biology of AIDS dementia complex.

1 reference

12 December 2020

Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy

1 reference

12 December 2020

Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy

1 reference

12 December 2020

Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study

1 reference

12 December 2020

Delayed central nervous system virus suppression during highly active antiretroviral therapy is associated with HIV encephalopathy, but not with viral drug resistance or poor central nervous system drug penetration

1 reference

12 December 2020

The AIDS dementia complex: I. Clinical features

1 reference

12 December 2020

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

1 reference

12 December 2020

Factors associated with incident human immunodeficiency virus-dementia

1 reference

12 December 2020

Pattern of neuropsychological performance among HIV positive patients in Uganda

1 reference

12 December 2020

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

12 December 2020

Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor

1 reference

12 December 2020

Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia

1 reference

12 December 2020

1 reference

12 December 2020

Changing patterns in the neuropathogenesis of HIV during the HAART era.

1 reference

12 December 2020

Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

1 reference

12 December 2020

Lopinavir concentrations in cerebrospinal fluid exceed the 50% inhibitory concentration for HIV.

1 reference

12 December 2020

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

12 December 2020

HIV-associated cognitive impairment before and after the advent of combination therapy

1 reference

12 December 2020

Cognitive impairment in asymptomatic stages of HIV infection. A longitudinal study.

1 reference

12 December 2020

Persistent brain abnormalities in antiretroviral-naive HIV patients 3 months after HAART.

1 reference

12 December 2020

Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes

1 reference

12 December 2020

Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy

1 reference

12 December 2020

Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function.

1 reference

12 December 2020

Highly active antiretroviral therapy improves neurocognitive functioning

1 reference

12 December 2020

Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease

1 reference

12 December 2020

The decline of incident cases of HIV-associated neurological disorders in San Francisco, 1991-2003.

1 reference

12 December 2020

Neuropsychological performance in symptomatic and asymptomatic HIV infection.

1 reference

12 December 2020

Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus

1 reference

12 December 2020

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

1 reference

12 December 2020

The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages

1 reference

12 December 2020

Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study

1 reference

12 December 2020

Antiretroviral therapy in HIV infection: are neurologically active drugs important?

1 reference

12 December 2020

10.1007/S11904-008-0011-7

Identifiers

DOI

1 reference

18 August 2017

1 reference